Covered recipient · General Payments record
SIDDHARTHA VARMA
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$6,543.61
- Reported across 427 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $222.27 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $190.49 | 17 |
| Lilly USA, LLC | $17.81 | 1 |
| Alexion Pharmaceuticals, Inc. | $13.97 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.20 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106272700 | CMS |
| ABBVIE INC. | $7.88 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106272702 | CMS |
| ABBVIE INC. | $6.10 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106272704 | CMS |
| ABBVIE INC. | $5.19 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106272706 | CMS |
| ABBVIE INC. | $7.71 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106272708 | CMS |
| ABBVIE INC. | $7.66 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106272710 | CMS |
| ABBVIE INC. | $6.43 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106272712 | CMS |
| ABBVIE INC. | $24.68 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106272714 | CMS |
| ABBVIE INC. | $29.86 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106272716 | CMS |
| ABBVIE INC. | $29.68 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106272718 | CMS |
| ABBVIE INC. | $5.93 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106272720 | CMS |
| ABBVIE INC. | $7.76 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106272722 | CMS |
| ABBVIE INC. | $9.95 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106272724 | CMS |
| ABBVIE INC. | $7.38 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106272726 | CMS |
| ABBVIE INC. | $7.64 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106272728 | CMS |
| ABBVIE INC. | $9.61 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106272730 | CMS |
| ABBVIE INC. | $8.83 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106272732 | CMS |
| Alexion Pharmaceuticals, Inc. | $13.97 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093990891 | CMS |
| Lilly USA, LLC | $17.81 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135419725 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.